Literature DB >> 19129559

Genomic changes of the 55 kDa subunit of DNA polymerase epsilon in human breast cancer.

Qi Zhou1, Reza Effati, Kati Talvinen, Helmut Pospiech, Juhani E Syväoja, Yrjö Collan.   

Abstract

BACKGROUND: DNA polymerases (Pols) represent potential candidates for cancer genes because of their central functions in DNA metabolism. Defects of some DNA Pols have shown cancer associations, but data on DNA polymerase (Pol) epsilon is limited.
MATERIALS AND METHODS: Twenty-four human breast cancer DNA samples and four control DNA samples were examined for possible mutation in the entire coding region of the 55 kDa small subunit of the human DNA Pol epsilon gene using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis of the DNA and sequence analysis. In addition, 20 control DNAs were studied with PCR-SSCP for the end of intron 18 and exon 19 region.
RESULTS: An AATT deletion was found at one location in intron 18 in 2 out of the 24 breast cancer cases (8%), but in none of the control cases. In addition, a single base transition was found in the cancer DNAs in intron 14, but the same changes were also found in the control DNAs, suggesting polymorphism.
CONCLUSION: Specific changes might occur in the 55 kDa small subunit DNA sequence of DNA Pol epsilon in breast cancer. The deletion at the region of intron-exon junction may not affect the protein code, but could potentially influence splicing efficiency and expression levels, possibly impairing the function of Pol epsilon DNA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19129559

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  6 in total

Review 1.  DNA replication fidelity and cancer.

Authors:  Bradley D Preston; Tina M Albertson; Alan J Herr
Journal:  Semin Cancer Biol       Date:  2010-10-15       Impact factor: 15.707

2.  POLE2 knockdown reduce tumorigenesis in esophageal squamous cells.

Authors:  Yongjun Zhu; Gang Chen; Yang Song; Zhiming Chen; Xiaofeng Chen
Journal:  Cancer Cell Int       Date:  2020-08-11       Impact factor: 5.722

3.  Knockdown of POLE2 expression suppresses lung adenocarcinoma cell malignant phenotypes in vitro.

Authors:  Jianying Li; Juanhong Wang; Jun Yu; Yuling Zhao; Ya Dong; Yali Fan; Namiao Li; Yingying Zhang; Yili Wang
Journal:  Oncol Rep       Date:  2018-08-17       Impact factor: 3.906

4.  The overexpression of DNA repair genes in invasive ductal and lobular breast carcinomas: Insights on individual variations and precision medicine.

Authors:  Ruwaa I Mohamed; Salma A Bargal; Asmaa S Mekawy; Iman El-Shiekh; Nurcan Tuncbag; Alaa S Ahmed; Eman Badr; Menattallah Elserafy
Journal:  PLoS One       Date:  2021-03-04       Impact factor: 3.240

5.  Targeting POLE2 Creates a Novel Vulnerability in Renal Cell Carcinoma via Modulating Stanniocalcin 1.

Authors:  Chuanjie Zhang; Yan Shen; Lili Gao; Xiaojing Wang; Da Huang; Xin Xie; Danfeng Xu; Hongchao He
Journal:  Front Cell Dev Biol       Date:  2021-02-11

6.  Berberine Inhibits FOXM1 Dependent Transcriptional Regulation of POLE2 and Interferes With the Survival of Lung Adenocarcinoma.

Authors:  Lulu Ni; Ping Sun; Xiaochun Fan; Zhongjie Li; Hongli Ren; Jiangan Li
Journal:  Front Pharmacol       Date:  2022-01-31       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.